The Future of Trust: "AI-Driven Biomedical Innovation: Accelerating Discovery and Expanding Access"

The Future of Trust: Artificial Intelligence in Fraud & Healthcare focused on AI in Fraud on day 1 and AI in healthcare on day 2. In this panel, "AI-Driven Biomedical Innovation: Accelerating Discovery and Expanding Access," hear from our panelists: Michael Ybarra, MD (Moderator) Chief Medical Officer & Senior Vice President | PhRMA Kirsten Tullia Executive Director | AdvaMed Digital Health Tech Pamela K. Gavin CEO | National Organization for Rare Disorders Peter Marks, MD, PhD Senior Vice President, Molecule Discovery and Head of Infectious Disease | Eli Lilly and Company